Sanofi SA (NASDAQ:SNY)

50.96
Delayed Data
As of 3:59pm ET
 +0.68 / +1.35%
Today’s Change
37.62
Today|||52-Week Range
52.94
+1.51%
Year-to-Date
2 Healthcare IPOs Getting a Tailwind From COVID-19 to Consider Buying
Jul 12 / MotleyFool.com - Paid Partner Content
Better Coronavirus Stock: Emergent Biosolutions vs. Regeneron
Jul 05 / MotleyFool.com - Paid Partner Content
Is It Too Late to Buy Novavax Stock?
Jul 10 / MotleyFool.com - Paid Partner Content
Regeneron's Arthritis Drug Fails COVID-19 Trial
Jul 03 / MotleyFool.com - Paid Partner Content
3 Top Biotech Stocks to Watch in July
Jul 09 / MotleyFool.com - Paid Partner Content
These 3 Things Could Send Novavax's Stock Soaring to New Heights
Jul 02 / MotleyFool.com - Paid Partner Content
GlaxoSmithKline Inks New COVID-19 Vaccine Research Pact
Jul 07 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close50.28
Today’s open51.18
Day’s range50.82 - 51.73
Volume36,003
Average volume (3 months)2,248,064
Market cap$126.1B
Data as of 3:59pm ET, 07/13/2020

Growth & Valuation

Earnings growth (last year)-36.29%
Earnings growth (this year)+2.98%
Earnings growth (next 5 years)+7.50%
Revenue growth (last year)-0.55%
P/E ratio38.8
Price/Sales3.12
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.34+0.59%
NVONovo Nordisk-0.29-0.44%
AZNAstraZeneca-0.49-0.91%
GSKGlaxoSmithKline+0.16+0.40%
Data as of 4:55pm ET, 07/13/2020

Financials

Last reporting date--
EPS forecast (this quarter)$0.71
Annual revenue (last year)$40.4B
Annual profit (last year)$3.3B
Net profit margin8.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Paris, Ile-de-france

Forecasts